About the C19 Gene Vaccine's
3d Genetic Vaccine development for infectious diseases summit
About the C19 Gene Vaccine's
Text to photo below;
Overcome the Translational Challenges of Developing mRNA, DNA & Viral Vector-Based Vaccines for Infectious Diseases
It has been a landmark year for gene-based vaccines once again, with the development of the first mRNA COVID-19 booster doses, approval of the world’s first DNA-based vaccine for human use, and the continued clinical development of viral vector-based vaccines.
-
Dedicated Streams
No matter what stage of vaccine development, whether its early discovery and pipeline evaluation or clinical development and IND-filing, gain access to content that’s right for you to ensure you remain competitive within the rapidly growing genetic vaccine market
-
Content Beyond COVID-19
With industry rapidly expanding mRNA, DNA, and viral vector-based technology beyond COVID-19 to other infectious diseases, gain access to novel and unpublished case studies and discover how newer platforms such as srRNA and AAV vectors hold great promise for previously unmet infections.
If you have received my substack by error i Apologies.
However to answer your question the point of this substack; is to bring forth the truth from the inside of the Genetic research community on the subject of Genetic Vaccine's & the technologies used.
Secondly and more importantly the legal points that has been overlooked such as Bio Terrorism, and more.
Nature will bite all of this tinkering with genetics on the arse. Not good for our wellbeing either way. Unfortunately.